RYR2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 1 Genetic Test
At DNA Labs UAE, we offer the RYR2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 1 Genetic Test. This test is designed to detect mutations in the RYR2 gene that may be associated with catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1), a rare inherited cardiac disorder.
Test Details
The RYR2 gene is responsible for encoding a protein called ryanodine receptor 2, which plays a crucial role in regulating calcium release during muscle contraction in cardiac muscle cells. Mutations in this gene can lead to CPVT1, a condition characterized by abnormal heart rhythms, specifically ventricular tachycardia.
Symptoms and Diagnosis
Individuals with CPVT1 may experience abnormal heart rhythms, such as ventricular tachycardia, which can be triggered by physical activity or emotional stress. These episodes can potentially lead to fainting, seizures, or even sudden cardiac arrest.
To diagnose CPVT1, we offer the RYR2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 1 Genetic Test. This test utilizes Next-Generation Sequencing (NGS) technology, allowing for the simultaneous analysis of multiple genes, including RYR2, to identify any potential mutations or variants associated with CPVT1.
Test Components and Price
Our RYR2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 1 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS technology for accurate and comprehensive results.
Test Type and Doctor
The RYR2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 1 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult with a cardiologist for this test.
Test Department and Pre-Test Information
The RYR2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 1 Genetic Test is conducted in our Genetics department. Before undergoing the test, it is essential to provide the clinical history of the patient and participate in a genetic counseling session to draw a pedigree chart of family members affected by CPVT1.
If you suspect you or someone you know may have CPVT1, we highly recommend consulting with a healthcare professional or a genetic counselor. They can provide guidance on appropriate genetic testing options and help interpret the results of the RYR2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 1 Genetic Test.
| Test Name | RYR2 Gene Ventricular tachycardia catecholaminergic polymorphic type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for RYR2 Gene Ventricular tachycardia, catecholaminergic polymorphic type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RYR2 Gene Ventricular tachycardia, catecholaminergic polymorphic type 1 NGS Genetic DNA Test gene RYR2 |
| Test Details | The RYR2 gene is responsible for encoding a protein called ryanodine receptor 2, which is found in cardiac muscle cells and plays a crucial role in regulating calcium release during muscle contraction. Mutations in the RYR2 gene can lead to a condition called catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1). CPVT1 is a rare inherited cardiac disorder characterized by abnormal heart rhythms, specifically ventricular tachycardia, which can be triggered by physical activity or emotional stress. These episodes can potentially lead to fainting, seizures, or even sudden cardiac arrest. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the RYR2 gene, to identify any potential mutations or variants that may be associated with CPVT1. This type of testing can provide a comprehensive assessment of an individual’s genetic makeup and help in diagnosing or confirming the presence of CPVT1. If you suspect you or someone you know may have CPVT1, it is recommended to consult with a healthcare professional or a genetic counselor who can provide guidance on appropriate genetic testing options and help interpret the results. |
